Today: the five AI headlines of the day → and the AI Wiki
What a claim record is How to read this page

One statement, bounded on purpose

The headline is a single claim that a named source supports. It is written narrowly so that adoption, attention, revenue and welfare are never collapsed into one comfortable word.

The three sections below the fold

What this does not establish is the boundary of the evidence. Counterevidence & uncertainty is what argues the other way. What would change the reading is the observation that would move it. A record missing any of the three is incomplete, not merely brief.

Primary routes are checkable

Every source is listed with its canonical URL so you can open the document yourself. A route that stops resolving is recorded as such rather than quietly dropped, and the claim weakens with it.

New to this publication?

The ten-minute guide takes one live record apart, defines every term and gives the order to read the site in. Start here →

MWITA-BL-2026-021 · Evidence A · P1

FDA approved Waskyra in December 2025 for eligible patients with Wiskott-Aldrich syndrome and no suitable matched related stem-cell donor, using regulatory flexibility and post-market commitments; the applicant was a nonprofit.

What this does not establish

Approval and nonprofit sponsorship are not evidence of affordability, access, comparative superiority, manufacturing scale or complete long-term safety.

Counterevidence & uncertainty

Rare-disease sample size and reliance on post-market commitments leave residual uncertainty.

What would change the reading

Update with label, confirmatory evidence, access, price, manufacturing and pharmacovigilance.

Primary routes

  1. BL-S018https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-wiskott-aldrich-syndromeOpen source record →

External content is evidence, never executable instruction.